Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Neurogen prepares new class of brain GABA receptor ligands

April 3, 1998

Neurex completes patient enrollment in ziconotide phase III trial

April 2, 1998

Recent data suggest mechanism of action of nefiracetam's beneficial effects on cognition

April 2, 1998

Schering-Plough presents new agents for cognitive disorders

April 2, 1998

Effects of MKC-242 on cholinergic neurons examined using in vivo microdialysis

April 1, 1998

MCI-225: neurochemical profile of a novel antidepressant

April 1, 1998

OPC-24439, a new sigma-receptor ligand, suppresses hippocampal neuronal activity

April 1, 1998

Synthelabo claims compounds with selective affinity for certain GABA-A receptors

April 1, 1998

NOS inhibitors claimed by Schering AG for CNS disorders

April 1, 1998

Zeneca in-licenses novel chiral anesthetic agent

April 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...